Results 161 to 170 of about 96,425 (243)

The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor

, 2010
Yuxin Li, Qiang Shen, Hee-Tae Kim, Reid P. Bissonnette, William W. Lamph, Bingfang Yan, Powel H. Brown   +6 more
openalex   +2 more sources

6-Gingerol induces cell-cycle G1-phase arrest through AKT–GSK 3β–cyclin D1 pathway in renal-cell carcinoma [PDF]

, 2019
Shan Xu, Haibao Zhang, Tianjie Liu, Wenjie Yang, Wei Lv, Dalin He, Peng Guo, Lei Li   +7 more
openalex   +1 more source

Auer Rod‐Like Inclusions in Chronic Lymphocytic Leukemia: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Auer rod‐like inclusions may occasionally be observed in chronic lymphocytic leukemia. Their recognition on peripheral smear highlights the importance of meticulous morphology assessment when comprehensive hematologic testing cannot be performed.
Tingting Zhang, Linjun Xie
wiley   +1 more source

A Growth-Promoting Signaling Component Cyclin D1 in Neural Stem Cells Has Antiastrogliogenic Function to Execute Self-Renewal [PDF]

, 2013
Norihisa Bizen, Toshihiro Inoue, Takeshi Shimizu, Kouichi Tabu, Tetsushi Kagawa, Tetsuya Taga   +5 more
openalex   +1 more source

Vildagliptin and Omarigliptin Differentially Bind to DPP‐4 Homodimers and Modulate Osteoclast‐Mediated Bone Resorption

Comprehensive Physiology, Volume 16, Issue 1, February 2026.
Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa, Jiraporn Panmanee, Jarinthorn Teerapornpuntakit, Kannikar Wongdee, Jirawan Thongbunchoo, Nattapon Panupinthu, Saovaros Svasti, Nattayaporn Apaijai, Piangkwan Sa‐nguanmoo, Siriporn Chattipakorn, Nipon Chattipakorn, Narattaphol Charoenphandhu   +11 more
wiley   +1 more source

Cyclin D1/CDK coordination with the cellular prion protein upregulated cell proliferation signaling and preserved neurological function in acute IS rats. [PDF]

Int J Biol Sci
Lin KC, Chen KH, Chiang JY, Chai HT, Huang CR, Chen YL, Wang YT, Guo J, Yip HK.   +8 more
europepmc   +1 more source

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma [PDF]

, 2006
Eva Schernhammer, Greg Tranah, Edward L. Giovannucci, Anthony T.�C. Chan, Jing Ma, Graham A. Colditz, David J. Hunter, W C Willett, C S Fuchs   +8 more
openalex   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

International Journal of Cancer, Volume 158, Issue 3, Page 488-502, 1 February 2026.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang   +7 more
wiley   +1 more source

TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1. [PDF]

Cell Oncol (Dordr)
Lu Y, Chen Y, Pan X, Ma W, Liu N, Yang L, Dong X, Guo H, Li D, Gan W.   +9 more
europepmc   +1 more source

MiR-145-5p arrests the cell cycle by modulating SMAD5/cyclin D1 to inhibit gastric cancer progression. [PDF]

Front Cell Dev Biol
Wang L, Guo J, Lv C, Kong L, Cui J, Wang Z, Guo Y, Jia R, Guan T, Yu B, Li F.   +10 more
europepmc   +1 more source